Psoriasis and the Excimer 308nm UVB Laser

Excimer 308nm UVB Laser treatment can be an extremely effective treatment option for patients suffering from plaque psoriasis. It has also proven useful in helping treat other conditions, including Vitiligo, Alopecia Areata and Hypopigmented Disorders like Lichen Planus / Mycosis Fungoides. Furthermore, XTRAC Excimer Laser offers targeted approaches for hard-to-reach areas like hands knees & feet using beams of UVB light emitting at 308nm wavelength which is most suitable in treating various dermatological conditions.

308nm light is generated using a laser that employs an isolated gas system composed of Xenon (Xe) and chlorogen atoms (XeCl). When combined, these elements create an excited dimer that is then dissociated by photomultipliers into UVB radiation that targets only lesional skin lesions while sparing normal tissue from exposure – an essential feature that ensures both efficacy and patient acceptance of laser treatment.

Psoriasis treatments using excimer 308nm laser radiation at fluences up to three medical exposure doses have proven highly successful at prompting rapid clearance and long-term remission, in comparison with narrowband UVB or conventional phototherapy, which require multiple sessions for efficacy.

Excimer laser therapy has proven highly successful at targeting and eliminating abnormal skin cells, inhibiting their proliferation and prompting their apoptosis – leading to rapid and long-lasting relief from psoriasis symptoms.

Excimer 308nm laser therapy has an outstanding track record in terms of both effectiveness and tolerability for most patients, with only minimal side effects – in comparison with many other treatment modalities for psoriasis such as phototherapy, biologic agents or scalp treatments which often come with substantial adverse reactions.

The Excimer 308nm UVB Laser has been demonstrated as being effective and safe in multiple studies for treating various dermatological diseases, such as vitiligo, alopecia areata, psoriasis, lichen planus and mycosis fuscus. Current clinical guidelines recommend its use for moderate to severe psoriasis covering 10% or more of body surface area, particularly for stubborn plaques on knees and elbows. Electrotherapy may also provide a viable treatment option for treating hypopigmented diseases that are unresponsive to traditional phototherapy treatments, such as vitiligo. Excimer laser treatment offers patients a quick and affordable route to remission, making it a popular option. Furthermore, its minimal treatment sessions and shorter remission periods make it a sought-after form of phototherapy for psoriasis. Excimer laser treatment offers significant cost-savings and increased convenience, since conventional phototherapy requires treating smaller patches only. Patients suffering from psoriasis are encouraged to consult their dermatologist regarding both benefits and risks before making their decision on this therapy treatment option.